Clinical trials

Durvalumab (MEDI4736) After chemoRadioTherapy for NSCLC patients
– a phase II translational and biomarker study investigating PDL1 positive and negative patients

More information

Nivolumab and Ipilimumab +/- UV1 vaccination as second line treatment in patients with malignant mesothelioma
– a phase II randomised clinical and translational trial

More information


NorPACT-2

 

Immunotherapy combined with extensive radiotherapy for the treatment of stage IV non-small cell lung cancer (COM-IT-2)
– a phase II randomised clinical and translational trial

More information

 

Norwegian Pancreatic Cancer
Trial (NorPACT)-2:
Liquid biopsies and blood-based
biomarkers
(https://www.ous-research.no/
pancreaticcancer)

 
Page visits: 4183